Chutes & Ladders—Biopharma veteran takes her CEO Cue
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Not long after the departure of former CEO Usman Azam, a new leader is taking her Cue in the form of Shao-Lee Lin, M.D., Ph.D. Lin steps into Cue’s president and chief exec spot after previously serving as founder and CEO of eye disease specialist Acelyrin, which later merged with Alumis. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene…
Not long after the departure of former CEO Usman Azam, a new leader is taking her Cue in the form of Shao-Lee Lin, M.D., Ph.D. Lin steps into Cue’s president and chief exec spot after previously serving as founder and CEO of eye disease specialist Acelyrin, which later merged with Alumis.
Source: FierceBiotech